Brief: Hyloris Pharmaceuticals Receives EUR 1 Mln In Non-Dilutive Funding From Walloon Region
08/06/2023 17:12
June 8 (Reuters) - Hyloris Pharmaceuticals SA HYL.BR :
* ANNOUNCED THAT COMPANY HAS BEEN GRANTED EUR 1 MILLION IN
NON-DILUTIVE FUNDING FROM WALLOON REGION FOR FIRST PART OF
DEVELOPMENT OF HY-083
Source text for Eikon: ID:nGNX6DQRql
Further company coverage: HYL.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Hyloris Pharmaceuticals SA
See all newsEurope Research Roundup: Akzo Nobel, MTU Aero Engines, Symrise
Brief: Hyloris Pharmaceuticals Says It Obtains Exclusive License Rights In Europe & Turkey From Arbormed For Its Wilson's Disease Therapy
Brief: Hyloris Announces Partnership With Rosemont Pharmaceuticals For Atomoxetine Oral Solution In The U.S.
Brief: Hyloris Announces Positive Study Results For Dofetilide IV
Brief: Hyloris Pharmaceuticals SA Says HY 2024 Revenues (Royalties And Milestones) Increased To EUR 4,2 Million